High expression of EPHX1, a microsomal epoxide hydrolase 1, is significantly associated with high recurrence and low overall survival rates in patients with AML [38], consistent with our findings, suggesting that EPHX1 may promote disease progression in AML. This evidence concerns the gene EPHX1 and acute myeloid leukemia.